Cytomegalovirus encephalitis in immunologically normal adults. Successful treatment with vidarabine.
Acute cytomegalovirus (CMV) encephalitis developed in two immunologically normal adults. The diagnosis was confirmed by isolation of CMV from the CSF and urine in one case and from temporal lobe biopsy tissue, CSF, and urine in the second case. Both patients were treated with vidarabine and showed dramatic clinical improvement. Virus excretion, which had been chronic in one case, cleared after therapy. To our knowledge, these are the first persons with CMV encephalitis evidenced by isolation of the virus from the CNS. The response to vidarabine was impressive and warrants further evaluation.
D000208:Acute Disease; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D002555:Cerebrospinal Fluid / Q000382:microbiology*; D003587:Cytomegalovirus / Q000276:immunology* / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000276:immunology; D004660:Encephalitis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013702:Temporal Lobe / Q000382:microbiology; D014556:Urine / Q000382:microbiology; D014740:Vidarabine / Q000627:therapeutic use*
D000914:Antibodies, Viral; D014740:Vidarabine